Retrospective AI-based measurement of NASH histology (AIM-NASH) analysis of biopsies from Phase 2 study of Resmetirom confirms significant treatment-induced changes in histologic features of non-alcoholic steatohepatitis
Year: 2022
Type: article
Source: Journal of Hepatology
Authors: Stephen Harrison, Janani Iyer, Charles Biddle-Snead, Sara Hoffman, Quang Le, Victoria Mountain, Murray Resnick, Katy Wack, Jim Hennan, Rebecca Taub
Institutions: University of Vienna, University of Groningen
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4283819269
